Log in

NYSE:CRLCharles River Laboratories Intl. Price Target & Analyst Ratings

-1.62 (-0.92 %)
(As of 05/25/2020 04:00 PM ET)
Today's Range
Now: $173.61
50-Day Range
MA: $145.40
52-Week Range
Now: $173.61
Volume255,849 shs
Average Volume440,474 shs
Market Capitalization$8.59 billion
P/E Ratio34.93
Dividend YieldN/A

Analyst Ratings

Charles River Laboratories Intl. (NYSE:CRL) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
18 Wall Street analysts have issued ratings and price targets for Charles River Laboratories Intl. in the last 12 months. Their average twelve-month price target is $171.33, suggesting that the stock has a possible downside of 1.31%. The high price target for CRL is $203.00 and the low price target for CRL is $139.00. There are currently 4 hold ratings, 13 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.832.822.802.62
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
13 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
12 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
10 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $171.33$162.18$171.33$152.64
Price Target Upside: 1.31% downside12.42% upside2.83% downside11.46% upside

Charles River Laboratories Intl. (NYSE:CRL) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Charles River Laboratories Intl. (NYSE:CRL) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/13/2020UBS GroupUpgradeNeutral ➝ Buy$177.00 ➝ $200.00Low
5/12/2020Deutsche BankLower Price TargetBuy$190.00 ➝ $174.00Medium
5/8/2020JPMorgan Chase & Co.Boost Price TargetOverweight$160.00 ➝ $180.00Low
5/8/2020Robert W. BairdBoost Price TargetOutperform$156.00 ➝ $175.00Low
5/8/2020Credit Suisse GroupLower Price TargetNeutral$162.00 ➝ $159.00Low
5/8/2020Morgan StanleyBoost Price TargetOverweight$152.00 ➝ $175.00Medium
5/8/2020CitigroupBoost Price TargetBuy$165.00 ➝ $190.00Medium
5/8/2020SunTrust BanksBoost Price TargetBuy$130.00 ➝ $194.00Medium
4/21/2020Jefferies Financial GroupDowngradeBuy ➝ Hold$139.00High
3/30/2020Wells Fargo & CoLower Price TargetOverweight$200.00 ➝ $145.00High
3/26/2020BarclaysLower Price TargetEqual Weight$170.00 ➝ $154.00High
2/18/2020Wolfe ResearchUpgradePeer Perform ➝ Outperform$169.00 ➝ $203.00Low
2/11/2020CfraBoost Price TargetStrong-Buy$165.00 ➝ $180.00Medium
1/10/2020Goldman Sachs GroupUpgradeNeutral ➝ Buy$143.00 ➝ $179.00Low
12/9/2019KeyCorpBoost Price TargetOverweight ➝ Overweight$151.00 ➝ $162.00Medium
11/19/2019ArgusReiterated RatingBuy$170.00Low
10/18/2019Bank of AmericaDowngradeBuy ➝ Neutral$150.00High
6/10/2019SVB LeerinkInitiated CoverageOutperform$155.00Low
4/30/2019Evercore ISIReiterated RatingOutperform ➝ Outperform$160.00Low
12/4/2018Raymond JamesReiterated RatingBuy$150.00Low
11/7/2018Royal Bank of CanadaSet Price TargetOutperform ➝ Buy$131.00 ➝ $147.00N/A
4/20/2018Mitsubishi UFJ Financial GroupInitiated CoverageNeutral$115.00Low
(Data available from 5/25/2018 forward)
This page was last updated on 5/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.